nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—L-Valine—Pregabalin—epilepsy syndrome	0.44	0.61	CrCrCtD
Penicillamine—L-Leucine—Pregabalin—epilepsy syndrome	0.281	0.39	CrCrCtD
Penicillamine—SLCO1B1—Transport of organic anions—SLCO1A2—epilepsy syndrome	0.00386	0.0841	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—SLCO1A2—epilepsy syndrome	0.00286	0.0623	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.00262	0.057	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.00194	0.0423	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC35A3—epilepsy syndrome	0.00189	0.0411	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC35A2—epilepsy syndrome	0.00189	0.0411	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.00167	0.0364	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—SLCO1A2—epilepsy syndrome	0.0015	0.0326	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLCO1A2—epilepsy syndrome	0.00143	0.0312	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCC2—epilepsy syndrome	0.00143	0.0312	CbGpPWpGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.00142	0.031	CbGpPWpGaD
Penicillamine—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.00139	0.0302	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—HSD17B4—epilepsy syndrome	0.00132	0.0287	CbGpPWpGaD
Penicillamine—L-Alanine—ABAT—epilepsy syndrome	0.00125	1	CrCbGaD
Penicillamine—SLCO1B1—Irinotecan Pathway—BCHE—epilepsy syndrome	0.00118	0.0257	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—APOD—epilepsy syndrome	0.00111	0.0243	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—AVP—epilepsy syndrome	0.00111	0.0242	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—epilepsy syndrome	0.00076	0.0165	CbGpPWpGaD
Penicillamine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—epilepsy syndrome	0.000758	0.0165	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of organic anions—ALB—epilepsy syndrome	0.000673	0.0147	CbGpPWpGaD
Penicillamine—SLCO1B1—Recycling of bile acids and salts—ALB—epilepsy syndrome	0.000499	0.0109	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—epilepsy syndrome	0.000412	0.00898	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC35A3—epilepsy syndrome	0.000406	0.00883	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC35A2—epilepsy syndrome	0.000406	0.00883	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC12A5—epilepsy syndrome	0.000406	0.00883	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC4A10—epilepsy syndrome	0.000371	0.00808	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC8A2—epilepsy syndrome	0.000308	0.0067	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLCO1A2—epilepsy syndrome	0.000308	0.0067	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC9A6—epilepsy syndrome	0.000308	0.0067	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC8A3—epilepsy syndrome	0.000293	0.00639	CbGpPWpGaD
Penicillamine—SLCO1B1—Bile acid and bile salt metabolism—ALB—epilepsy syndrome	0.000261	0.00568	CbGpPWpGaD
Penicillamine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—epilepsy syndrome	0.00025	0.00544	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—APOD—epilepsy syndrome	0.000239	0.00521	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A1—epilepsy syndrome	0.000233	0.00507	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC12A2—epilepsy syndrome	0.000233	0.00507	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000231	0.00504	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000231	0.00504	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000217	0.00472	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000217	0.00472	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000213	0.00464	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000206	0.00449	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000206	0.00449	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000206	0.00449	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000198	0.00431	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000189	0.00411	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000174	0.0038	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000168	0.00367	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000165	0.00359	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000164	0.00358	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000156	0.0034	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000156	0.0034	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000156	0.0034	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00015	0.00327	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.00015	0.00327	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000149	0.00325	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000149	0.00325	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000145	0.00315	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.000131	0.00286	CbGpPWpGaD
Penicillamine—Arthralgia—Lamotrigine—epilepsy syndrome	0.000131	0.000567	CcSEcCtD
Penicillamine—Tinnitus—Valproic Acid—epilepsy syndrome	0.000131	0.000567	CcSEcCtD
Penicillamine—Anorexia—Clonazepam—epilepsy syndrome	0.000131	0.000566	CcSEcCtD
Penicillamine—Anxiety—Lamotrigine—epilepsy syndrome	0.000131	0.000565	CcSEcCtD
Penicillamine—Decreased appetite—Diazepam—epilepsy syndrome	0.000131	0.000565	CcSEcCtD
Penicillamine—Urticaria—Midazolam—epilepsy syndrome	0.000131	0.000564	CcSEcCtD
Penicillamine—Anorexia—Phenytoin—epilepsy syndrome	0.00013	0.000562	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.00013	0.000561	CcSEcCtD
Penicillamine—Abdominal pain upper—Topiramate—epilepsy syndrome	0.00013	0.00056	CcSEcCtD
Penicillamine—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000129	0.000559	CcSEcCtD
Penicillamine—Vomiting—Clobazam—epilepsy syndrome	0.000129	0.000558	CcSEcCtD
Penicillamine—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000128	0.000555	CcSEcCtD
Penicillamine—Rash—Clobazam—epilepsy syndrome	0.000128	0.000553	CcSEcCtD
Penicillamine—Dermatitis—Clobazam—epilepsy syndrome	0.000128	0.000553	CcSEcCtD
Penicillamine—Haemoglobin—Pregabalin—epilepsy syndrome	0.000128	0.000553	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Topiramate—epilepsy syndrome	0.000128	0.000552	CcSEcCtD
Penicillamine—Renal failure—Gabapentin—epilepsy syndrome	0.000128	0.000552	CcSEcCtD
Penicillamine—Angiopathy—Valproic Acid—epilepsy syndrome	0.000128	0.000552	CcSEcCtD
Penicillamine—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000127	0.000551	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—CA13—epilepsy syndrome	0.000127	0.00277	CbGpPWpGaD
Penicillamine—Neuropathy peripheral—Gabapentin—epilepsy syndrome	0.000127	0.00055	CcSEcCtD
Penicillamine—Haemorrhage—Pregabalin—epilepsy syndrome	0.000127	0.00055	CcSEcCtD
Penicillamine—Stomatitis—Gabapentin—epilepsy syndrome	0.000127	0.000547	CcSEcCtD
Penicillamine—Decreased appetite—Felbamate—epilepsy syndrome	0.000126	0.000547	CcSEcCtD
Penicillamine—Skin disorder—Carbamazepine—epilepsy syndrome	0.000126	0.000546	CcSEcCtD
Penicillamine—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000126	0.000543	CcSEcCtD
Penicillamine—Muscular weakness—Topiramate—epilepsy syndrome	0.000125	0.000541	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000125	0.000541	CcSEcCtD
Penicillamine—Urethral disorder—Pregabalin—epilepsy syndrome	0.000125	0.000539	CcSEcCtD
Penicillamine—Urticaria—Fosphenytoin—epilepsy syndrome	0.000124	0.000538	CcSEcCtD
Penicillamine—Alopecia—Valproic Acid—epilepsy syndrome	0.000124	0.000537	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000124	0.000537	CcSEcCtD
Penicillamine—Nausea—Lacosamide—epilepsy syndrome	0.000124	0.000537	CcSEcCtD
Penicillamine—Anorexia—Carbamazepine—epilepsy syndrome	0.000124	0.000536	CcSEcCtD
Penicillamine—Haematuria—Gabapentin—epilepsy syndrome	0.000124	0.000535	CcSEcCtD
Penicillamine—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000124	0.000535	CcSEcCtD
Penicillamine—Decreased appetite—Zonisamide—epilepsy syndrome	0.000124	0.000535	CcSEcCtD
Penicillamine—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000124	0.000535	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.000124	0.000534	CcSEcCtD
Penicillamine—Mental disorder—Valproic Acid—epilepsy syndrome	0.000123	0.000533	CcSEcCtD
Penicillamine—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000123	0.000532	CcSEcCtD
Penicillamine—Hepatobiliary disease—Gabapentin—epilepsy syndrome	0.000123	0.000531	CcSEcCtD
Penicillamine—Asthma—Topiramate—epilepsy syndrome	0.000123	0.00053	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	0.000122	0.00265	CbGpPWpGaD
Penicillamine—Eosinophilia—Topiramate—epilepsy syndrome	0.000121	0.000525	CcSEcCtD
Penicillamine—Urticaria—Vigabatrin—epilepsy syndrome	0.000121	0.000524	CcSEcCtD
Penicillamine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000121	0.000523	CcSEcCtD
Penicillamine—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000121	0.000522	CcSEcCtD
Penicillamine—Nausea—Clobazam—epilepsy syndrome	0.000121	0.000521	CcSEcCtD
Penicillamine—Pancreatitis—Topiramate—epilepsy syndrome	0.00012	0.00052	CcSEcCtD
Penicillamine—Dysgeusia—Valproic Acid—epilepsy syndrome	0.00012	0.000518	CcSEcCtD
Penicillamine—Anorexia—Lamotrigine—epilepsy syndrome	0.00012	0.000518	CcSEcCtD
Penicillamine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.00012	0.000517	CcSEcCtD
Penicillamine—Urticaria—Diazepam—epilepsy syndrome	0.000119	0.000516	CcSEcCtD
Penicillamine—Decreased appetite—Clonazepam—epilepsy syndrome	0.000119	0.000516	CcSEcCtD
Penicillamine—Tinnitus—Pregabalin—epilepsy syndrome	0.000119	0.000513	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000119	0.000513	CcSEcCtD
Penicillamine—Decreased appetite—Phenytoin—epilepsy syndrome	0.000119	0.000512	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	0.000118	0.00258	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	0.000118	0.00258	CbGpPWpGaD
Penicillamine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000118	0.00051	CcSEcCtD
Penicillamine—Haemorrhage—Gabapentin—epilepsy syndrome	0.000117	0.000504	CcSEcCtD
Penicillamine—Pancytopenia—Topiramate—epilepsy syndrome	0.000116	0.000503	CcSEcCtD
Penicillamine—Urticaria—Felbamate—epilepsy syndrome	0.000116	0.0005	CcSEcCtD
Penicillamine—Angiopathy—Pregabalin—epilepsy syndrome	0.000115	0.000499	CcSEcCtD
Penicillamine—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000115	0.000498	CcSEcCtD
Penicillamine—Body temperature increased—Felbamate—epilepsy syndrome	0.000115	0.000497	CcSEcCtD
Penicillamine—Vomiting—Acetazolamide—epilepsy syndrome	0.000115	0.000497	CcSEcCtD
Penicillamine—Diarrhoea—Propofol—epilepsy syndrome	0.000115	0.000497	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000115	0.000495	CcSEcCtD
Penicillamine—Urethral disorder—Gabapentin—epilepsy syndrome	0.000114	0.000494	CcSEcCtD
Penicillamine—Anaemia—Valproic Acid—epilepsy syndrome	0.000113	0.000489	CcSEcCtD
Penicillamine—Urticaria—Zonisamide—epilepsy syndrome	0.000113	0.000489	CcSEcCtD
Penicillamine—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000113	0.000489	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	0.000113	0.00246	CbGpPWpGaD
Penicillamine—Body temperature increased—Zonisamide—epilepsy syndrome	0.000113	0.000487	CcSEcCtD
Penicillamine—Agitation—Valproic Acid—epilepsy syndrome	0.000113	0.000486	CcSEcCtD
Penicillamine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000113	0.000486	CcSEcCtD
Penicillamine—Alopecia—Pregabalin—epilepsy syndrome	0.000112	0.000486	CcSEcCtD
Penicillamine—Mental disorder—Pregabalin—epilepsy syndrome	0.000111	0.000482	CcSEcCtD
Penicillamine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000111	0.00048	CcSEcCtD
Penicillamine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000111	0.000479	CcSEcCtD
Penicillamine—Leukopenia—Valproic Acid—epilepsy syndrome	0.00011	0.000474	CcSEcCtD
Penicillamine—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000109	0.000473	CcSEcCtD
Penicillamine—Urticaria—Clonazepam—epilepsy syndrome	0.000109	0.000471	CcSEcCtD
Penicillamine—Tinnitus—Gabapentin—epilepsy syndrome	0.000109	0.00047	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	0.000109	0.00236	CbGpPWpGaD
Penicillamine—Body temperature increased—Clonazepam—epilepsy syndrome	0.000109	0.000469	CcSEcCtD
Penicillamine—Dysgeusia—Pregabalin—epilepsy syndrome	0.000108	0.000469	CcSEcCtD
Penicillamine—Urticaria—Phenytoin—epilepsy syndrome	0.000108	0.000468	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	0.000108	0.00236	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	0.000108	0.00236	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	0.000108	0.00236	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	0.000108	0.00236	CbGpPWpGaD
Penicillamine—Body temperature increased—Phenytoin—epilepsy syndrome	0.000108	0.000466	CcSEcCtD
Penicillamine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000108	0.000466	CcSEcCtD
Penicillamine—Renal failure—Topiramate—epilepsy syndrome	0.000107	0.000464	CcSEcCtD
Penicillamine—Nausea—Acetazolamide—epilepsy syndrome	0.000107	0.000464	CcSEcCtD
Penicillamine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000107	0.000463	CcSEcCtD
Penicillamine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000107	0.000463	CcSEcCtD
Penicillamine—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000107	0.000463	CcSEcCtD
Penicillamine—Vomiting—Propofol—epilepsy syndrome	0.000107	0.000462	CcSEcCtD
Penicillamine—Stomatitis—Topiramate—epilepsy syndrome	0.000107	0.000461	CcSEcCtD
Penicillamine—Rash—Propofol—epilepsy syndrome	0.000106	0.000458	CcSEcCtD
Penicillamine—Dermatitis—Propofol—epilepsy syndrome	0.000106	0.000457	CcSEcCtD
Penicillamine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000105	0.000454	CcSEcCtD
Penicillamine—Vomiting—Midazolam—epilepsy syndrome	0.000105	0.000452	CcSEcCtD
Penicillamine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000104	0.000452	CcSEcCtD
Penicillamine—Arthralgia—Valproic Acid—epilepsy syndrome	0.000104	0.000451	CcSEcCtD
Penicillamine—Haematuria—Topiramate—epilepsy syndrome	0.000104	0.00045	CcSEcCtD
Penicillamine—Anxiety—Valproic Acid—epilepsy syndrome	0.000104	0.000449	CcSEcCtD
Penicillamine—Rash—Midazolam—epilepsy syndrome	0.000104	0.000448	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000104	0.000448	CcSEcCtD
Penicillamine—Dermatitis—Midazolam—epilepsy syndrome	0.000104	0.000448	CcSEcCtD
Penicillamine—Urticaria—Carbamazepine—epilepsy syndrome	0.000103	0.000447	CcSEcCtD
Penicillamine—Vomiting—Levetiracetam—epilepsy syndrome	0.000103	0.000446	CcSEcCtD
Penicillamine—Alopecia—Gabapentin—epilepsy syndrome	0.000103	0.000445	CcSEcCtD
Penicillamine—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000103	0.000445	CcSEcCtD
Penicillamine—Diarrhoea—Diazepam—epilepsy syndrome	0.000103	0.000445	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000103	0.00223	CbGpPWpGaD
Penicillamine—Rash—Levetiracetam—epilepsy syndrome	0.000102	0.000442	CcSEcCtD
Penicillamine—Anaemia—Pregabalin—epilepsy syndrome	0.000102	0.000442	CcSEcCtD
Penicillamine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000102	0.000442	CcSEcCtD
Penicillamine—Mental disorder—Gabapentin—epilepsy syndrome	0.000102	0.000442	CcSEcCtD
Penicillamine—Agranulocytosis—Topiramate—epilepsy syndrome	0.000102	0.000441	CcSEcCtD
Penicillamine—Agitation—Pregabalin—epilepsy syndrome	0.000102	0.00044	CcSEcCtD
Penicillamine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000101	0.000437	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	0.000101	0.00219	CbGpPWpGaD
Penicillamine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.0001	0.000434	CcSEcCtD
Penicillamine—Urticaria—Lamotrigine—epilepsy syndrome	9.99e-05	0.000432	CcSEcCtD
Penicillamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.99e-05	0.000432	CcSEcCtD
Penicillamine—Nausea—Propofol—epilepsy syndrome	9.98e-05	0.000431	CcSEcCtD
Penicillamine—Vomiting—Fosphenytoin—epilepsy syndrome	9.96e-05	0.000431	CcSEcCtD
Penicillamine—Diarrhoea—Felbamate—epilepsy syndrome	9.96e-05	0.00043	CcSEcCtD
Penicillamine—Body temperature increased—Lamotrigine—epilepsy syndrome	9.94e-05	0.00043	CcSEcCtD
Penicillamine—Dysgeusia—Gabapentin—epilepsy syndrome	9.94e-05	0.00043	CcSEcCtD
Penicillamine—Leukopenia—Pregabalin—epilepsy syndrome	9.91e-05	0.000428	CcSEcCtD
Penicillamine—Rash—Fosphenytoin—epilepsy syndrome	9.88e-05	0.000427	CcSEcCtD
Penicillamine—Dermatitis—Fosphenytoin—epilepsy syndrome	9.87e-05	0.000427	CcSEcCtD
Penicillamine—Haemoglobin—Topiramate—epilepsy syndrome	9.86e-05	0.000426	CcSEcCtD
Penicillamine—Haemorrhage—Topiramate—epilepsy syndrome	9.81e-05	0.000424	CcSEcCtD
Penicillamine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	9.79e-05	0.000423	CcSEcCtD
Penicillamine—Nausea—Midazolam—epilepsy syndrome	9.76e-05	0.000422	CcSEcCtD
Penicillamine—Diarrhoea—Zonisamide—epilepsy syndrome	9.75e-05	0.000421	CcSEcCtD
Penicillamine—Vomiting—Vigabatrin—epilepsy syndrome	9.71e-05	0.00042	CcSEcCtD
Penicillamine—Skin disorder—Valproic Acid—epilepsy syndrome	9.71e-05	0.00042	CcSEcCtD
Penicillamine—Urinary tract disorder—Topiramate—epilepsy syndrome	9.69e-05	0.000419	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—PDXK—epilepsy syndrome	9.66e-05	0.0021	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GLUD1—epilepsy syndrome	9.66e-05	0.0021	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—L2HGDH—epilepsy syndrome	9.66e-05	0.0021	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADK—epilepsy syndrome	9.66e-05	0.0021	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—FAR1—epilepsy syndrome	9.66e-05	0.0021	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CERS1—epilepsy syndrome	9.66e-05	0.0021	CbGpPWpGaD
Penicillamine—Nausea—Levetiracetam—epilepsy syndrome	9.64e-05	0.000417	CcSEcCtD
Penicillamine—Rash—Vigabatrin—epilepsy syndrome	9.63e-05	0.000416	CcSEcCtD
Penicillamine—Dermatitis—Vigabatrin—epilepsy syndrome	9.62e-05	0.000416	CcSEcCtD
Penicillamine—Urethral disorder—Topiramate—epilepsy syndrome	9.62e-05	0.000416	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	9.61e-05	0.00209	CbGpPWpGaD
Penicillamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.59e-05	0.000414	CcSEcCtD
Penicillamine—Vomiting—Diazepam—epilepsy syndrome	9.56e-05	0.000413	CcSEcCtD
Penicillamine—Anorexia—Valproic Acid—epilepsy syndrome	9.53e-05	0.000412	CcSEcCtD
Penicillamine—Rash—Diazepam—epilepsy syndrome	9.48e-05	0.00041	CcSEcCtD
Penicillamine—Dermatitis—Diazepam—epilepsy syndrome	9.47e-05	0.000409	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	9.47e-05	0.00206	CbGpPWpGaD
Penicillamine—Arthralgia—Pregabalin—epilepsy syndrome	9.43e-05	0.000407	CcSEcCtD
Penicillamine—Anxiety—Pregabalin—epilepsy syndrome	9.39e-05	0.000406	CcSEcCtD
Penicillamine—Diarrhoea—Clonazepam—epilepsy syndrome	9.39e-05	0.000406	CcSEcCtD
Penicillamine—Anaemia—Gabapentin—epilepsy syndrome	9.38e-05	0.000406	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.36e-05	0.000405	CcSEcCtD
Penicillamine—Agitation—Gabapentin—epilepsy syndrome	9.33e-05	0.000403	CcSEcCtD
Penicillamine—Diarrhoea—Phenytoin—epilepsy syndrome	9.33e-05	0.000403	CcSEcCtD
Penicillamine—Nausea—Fosphenytoin—epilepsy syndrome	9.31e-05	0.000402	CcSEcCtD
Penicillamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.28e-05	0.000401	CcSEcCtD
Penicillamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.27e-05	0.000401	CcSEcCtD
Penicillamine—Vomiting—Felbamate—epilepsy syndrome	9.25e-05	0.0004	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	9.21e-05	0.00201	CbGpPWpGaD
Penicillamine—Rash—Felbamate—epilepsy syndrome	9.18e-05	0.000397	CcSEcCtD
Penicillamine—Dermatitis—Felbamate—epilepsy syndrome	9.17e-05	0.000396	CcSEcCtD
Penicillamine—Tinnitus—Topiramate—epilepsy syndrome	9.15e-05	0.000395	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.11e-05	0.000394	CcSEcCtD
Penicillamine—Leukopenia—Gabapentin—epilepsy syndrome	9.09e-05	0.000393	CcSEcCtD
Penicillamine—Nausea—Vigabatrin—epilepsy syndrome	9.07e-05	0.000392	CcSEcCtD
Penicillamine—Vomiting—Zonisamide—epilepsy syndrome	9.06e-05	0.000391	CcSEcCtD
Penicillamine—Rash—Zonisamide—epilepsy syndrome	8.98e-05	0.000388	CcSEcCtD
Penicillamine—Dermatitis—Zonisamide—epilepsy syndrome	8.97e-05	0.000388	CcSEcCtD
Penicillamine—Nausea—Diazepam—epilepsy syndrome	8.93e-05	0.000386	CcSEcCtD
Penicillamine—Diarrhoea—Carbamazepine—epilepsy syndrome	8.91e-05	0.000385	CcSEcCtD
Penicillamine—Angiopathy—Topiramate—epilepsy syndrome	8.9e-05	0.000385	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	8.87e-05	0.00193	CbGpPWpGaD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	8.85e-05	0.00193	CbGpPWpGaD
Penicillamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	8.85e-05	0.000382	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—NHLRC1—epilepsy syndrome	8.83e-05	0.00192	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GAMT—epilepsy syndrome	8.83e-05	0.00192	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PNPO—epilepsy syndrome	8.83e-05	0.00192	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—EPM2A—epilepsy syndrome	8.83e-05	0.00192	CbGpPWpGaD
Penicillamine—Skin disorder—Pregabalin—epilepsy syndrome	8.78e-05	0.000379	CcSEcCtD
Penicillamine—Vomiting—Clonazepam—epilepsy syndrome	8.73e-05	0.000377	CcSEcCtD
Penicillamine—Decreased appetite—Valproic Acid—epilepsy syndrome	8.69e-05	0.000376	CcSEcCtD
Penicillamine—Alopecia—Topiramate—epilepsy syndrome	8.67e-05	0.000375	CcSEcCtD
Penicillamine—Vomiting—Phenytoin—epilepsy syndrome	8.67e-05	0.000375	CcSEcCtD
Penicillamine—Rash—Clonazepam—epilepsy syndrome	8.66e-05	0.000374	CcSEcCtD
Penicillamine—Dermatitis—Clonazepam—epilepsy syndrome	8.65e-05	0.000374	CcSEcCtD
Penicillamine—Arthralgia—Gabapentin—epilepsy syndrome	8.64e-05	0.000374	CcSEcCtD
Penicillamine—Nausea—Felbamate—epilepsy syndrome	8.64e-05	0.000374	CcSEcCtD
Penicillamine—Vomiting—Oxcarbazepine—epilepsy syndrome	8.62e-05	0.000373	CcSEcCtD
Penicillamine—Anxiety—Gabapentin—epilepsy syndrome	8.61e-05	0.000372	CcSEcCtD
Penicillamine—Anorexia—Pregabalin—epilepsy syndrome	8.61e-05	0.000372	CcSEcCtD
Penicillamine—Diarrhoea—Lamotrigine—epilepsy syndrome	8.61e-05	0.000372	CcSEcCtD
Penicillamine—Rash—Phenytoin—epilepsy syndrome	8.6e-05	0.000372	CcSEcCtD
Penicillamine—Mental disorder—Topiramate—epilepsy syndrome	8.6e-05	0.000372	CcSEcCtD
Penicillamine—Dermatitis—Phenytoin—epilepsy syndrome	8.59e-05	0.000371	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.58e-05	0.000371	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	8.56e-05	0.00186	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	8.56e-05	0.00186	CbGpPWpGaD
Penicillamine—Rash—Oxcarbazepine—epilepsy syndrome	8.55e-05	0.00037	CcSEcCtD
Penicillamine—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.54e-05	0.000369	CcSEcCtD
Penicillamine—Nausea—Zonisamide—epilepsy syndrome	8.46e-05	0.000366	CcSEcCtD
Penicillamine—Dysgeusia—Topiramate—epilepsy syndrome	8.37e-05	0.000362	CcSEcCtD
Penicillamine—Vomiting—Carbamazepine—epilepsy syndrome	8.28e-05	0.000358	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.23e-05	0.000356	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—QDPR—epilepsy syndrome	8.21e-05	0.00179	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CA4—epilepsy syndrome	8.21e-05	0.00179	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	8.21e-05	0.00179	CbGpPWpGaD
Penicillamine—Rash—Carbamazepine—epilepsy syndrome	8.21e-05	0.000355	CcSEcCtD
Penicillamine—Dermatitis—Carbamazepine—epilepsy syndrome	8.2e-05	0.000354	CcSEcCtD
Penicillamine—Nausea—Clonazepam—epilepsy syndrome	8.15e-05	0.000352	CcSEcCtD
Penicillamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	8.11e-05	0.000351	CcSEcCtD
Penicillamine—Nausea—Phenytoin—epilepsy syndrome	8.1e-05	0.00035	CcSEcCtD
Penicillamine—Nausea—Oxcarbazepine—epilepsy syndrome	8.06e-05	0.000348	CcSEcCtD
Penicillamine—Skin disorder—Gabapentin—epilepsy syndrome	8.05e-05	0.000348	CcSEcCtD
Penicillamine—Vomiting—Lamotrigine—epilepsy syndrome	8e-05	0.000346	CcSEcCtD
Penicillamine—Urticaria—Valproic Acid—epilepsy syndrome	7.94e-05	0.000343	CcSEcCtD
Penicillamine—Rash—Lamotrigine—epilepsy syndrome	7.93e-05	0.000343	CcSEcCtD
Penicillamine—Dermatitis—Lamotrigine—epilepsy syndrome	7.92e-05	0.000342	CcSEcCtD
Penicillamine—Body temperature increased—Valproic Acid—epilepsy syndrome	7.9e-05	0.000342	CcSEcCtD
Penicillamine—Anorexia—Gabapentin—epilepsy syndrome	7.9e-05	0.000341	CcSEcCtD
Penicillamine—Anaemia—Topiramate—epilepsy syndrome	7.9e-05	0.000341	CcSEcCtD
Penicillamine—Decreased appetite—Pregabalin—epilepsy syndrome	7.86e-05	0.00034	CcSEcCtD
Penicillamine—Agitation—Topiramate—epilepsy syndrome	7.85e-05	0.000339	CcSEcCtD
Penicillamine—Nausea—Carbamazepine—epilepsy syndrome	7.73e-05	0.000334	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—COX3—epilepsy syndrome	7.72e-05	0.00168	CbGpPWpGaD
Penicillamine—Leukopenia—Topiramate—epilepsy syndrome	7.65e-05	0.00033	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	7.63e-05	0.00166	CbGpPWpGaD
Penicillamine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.55e-05	0.000326	CcSEcCtD
Penicillamine—Nausea—Lamotrigine—epilepsy syndrome	7.47e-05	0.000323	CcSEcCtD
Penicillamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.36e-05	0.000318	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—CACNA2D2—epilepsy syndrome	7.32e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLCO1A2—epilepsy syndrome	7.32e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PFKL—epilepsy syndrome	7.32e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—KCNB1—epilepsy syndrome	7.32e-05	0.00159	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC6A8—epilepsy syndrome	7.32e-05	0.00159	CbGpPWpGaD
Penicillamine—Arthralgia—Topiramate—epilepsy syndrome	7.27e-05	0.000314	CcSEcCtD
Penicillamine—Anxiety—Topiramate—epilepsy syndrome	7.25e-05	0.000313	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.22e-05	0.000312	CcSEcCtD
Penicillamine—Decreased appetite—Gabapentin—epilepsy syndrome	7.2e-05	0.000311	CcSEcCtD
Penicillamine—Urticaria—Pregabalin—epilepsy syndrome	7.18e-05	0.00031	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	7.15e-05	0.00156	CbGpPWpGaD
Penicillamine—Body temperature increased—Pregabalin—epilepsy syndrome	7.14e-05	0.000309	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	7.11e-05	0.00155	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	6.98e-05	0.00152	CbGpPWpGaD
Penicillamine—Diarrhoea—Valproic Acid—epilepsy syndrome	6.84e-05	0.000296	CcSEcCtD
Penicillamine—Thrombocytopenia—Topiramate—epilepsy syndrome	6.83e-05	0.000295	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	6.8e-05	0.00148	CbGpPWpGaD
Penicillamine—Skin disorder—Topiramate—epilepsy syndrome	6.77e-05	0.000293	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—ATIC—epilepsy syndrome	6.69e-05	0.00146	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—NEU1—epilepsy syndrome	6.69e-05	0.00146	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—UPB1—epilepsy syndrome	6.69e-05	0.00146	CbGpPWpGaD
Penicillamine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.66e-05	0.000288	CcSEcCtD
Penicillamine—Anorexia—Topiramate—epilepsy syndrome	6.65e-05	0.000287	CcSEcCtD
Penicillamine—Urticaria—Gabapentin—epilepsy syndrome	6.58e-05	0.000285	CcSEcCtD
Penicillamine—Body temperature increased—Gabapentin—epilepsy syndrome	6.55e-05	0.000283	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—HSD17B4—epilepsy syndrome	6.44e-05	0.0014	CbGpPWpGaD
Penicillamine—Vomiting—Valproic Acid—epilepsy syndrome	6.36e-05	0.000275	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.35e-05	0.000275	CcSEcCtD
Penicillamine—Rash—Valproic Acid—epilepsy syndrome	6.3e-05	0.000272	CcSEcCtD
Penicillamine—Dermatitis—Valproic Acid—epilepsy syndrome	6.3e-05	0.000272	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—PPP1R3C—epilepsy syndrome	6.22e-05	0.00135	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GBE1—epilepsy syndrome	6.22e-05	0.00135	CbGpPWpGaD
Penicillamine—Diarrhoea—Pregabalin—epilepsy syndrome	6.18e-05	0.000267	CcSEcCtD
Penicillamine—Hypersensitivity—Gabapentin—epilepsy syndrome	6.11e-05	0.000264	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	6.08e-05	0.00132	CbGpPWpGaD
Penicillamine—Decreased appetite—Topiramate—epilepsy syndrome	6.06e-05	0.000262	CcSEcCtD
Penicillamine—Nausea—Valproic Acid—epilepsy syndrome	5.94e-05	0.000257	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—ASAH1—epilepsy syndrome	5.85e-05	0.00127	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	5.78e-05	0.00126	CbGpPWpGaD
Penicillamine—Vomiting—Pregabalin—epilepsy syndrome	5.75e-05	0.000248	CcSEcCtD
Penicillamine—Rash—Pregabalin—epilepsy syndrome	5.7e-05	0.000246	CcSEcCtD
Penicillamine—Dermatitis—Pregabalin—epilepsy syndrome	5.69e-05	0.000246	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—STXBP1—epilepsy syndrome	5.69e-05	0.00124	CbGpPWpGaD
Penicillamine—Diarrhoea—Gabapentin—epilepsy syndrome	5.67e-05	0.000245	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—NT5E—epilepsy syndrome	5.55e-05	0.00121	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALAD—epilepsy syndrome	5.55e-05	0.00121	CbGpPWpGaD
Penicillamine—Urticaria—Topiramate—epilepsy syndrome	5.54e-05	0.000239	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	5.52e-05	0.0012	CbGpPWpGaD
Penicillamine—Body temperature increased—Topiramate—epilepsy syndrome	5.51e-05	0.000238	CcSEcCtD
Penicillamine—Nausea—Pregabalin—epilepsy syndrome	5.37e-05	0.000232	CcSEcCtD
Penicillamine—SLCO1B1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	5.36e-05	0.00117	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CACNA1A—epilepsy syndrome	5.29e-05	0.00115	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALDH7A1—epilepsy syndrome	5.29e-05	0.00115	CbGpPWpGaD
Penicillamine—Vomiting—Gabapentin—epilepsy syndrome	5.27e-05	0.000228	CcSEcCtD
Penicillamine—Rash—Gabapentin—epilepsy syndrome	5.22e-05	0.000226	CcSEcCtD
Penicillamine—Dermatitis—Gabapentin—epilepsy syndrome	5.22e-05	0.000226	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—ST3GAL3—epilepsy syndrome	5.18e-05	0.00113	CbGpPWpGaD
Penicillamine—Hypersensitivity—Topiramate—epilepsy syndrome	5.14e-05	0.000222	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—ADSL—epilepsy syndrome	5.07e-05	0.0011	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GLUL—epilepsy syndrome	4.98e-05	0.00108	CbGpPWpGaD
Penicillamine—Nausea—Gabapentin—epilepsy syndrome	4.92e-05	0.000213	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—CACNA1D—epilepsy syndrome	4.88e-05	0.00106	CbGpPWpGaD
Penicillamine—Diarrhoea—Topiramate—epilepsy syndrome	4.77e-05	0.000206	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—TXNRD1—epilepsy syndrome	4.57e-05	0.000994	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	4.54e-05	0.000988	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	4.5e-05	0.000979	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AQP1—epilepsy syndrome	4.43e-05	0.000965	CbGpPWpGaD
Penicillamine—Vomiting—Topiramate—epilepsy syndrome	4.43e-05	0.000192	CcSEcCtD
Penicillamine—Rash—Topiramate—epilepsy syndrome	4.4e-05	0.00019	CcSEcCtD
Penicillamine—Dermatitis—Topiramate—epilepsy syndrome	4.39e-05	0.00019	CcSEcCtD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	4.36e-05	0.000948	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.26e-05	0.000927	CbGpPWpGaD
Penicillamine—Nausea—Topiramate—epilepsy syndrome	4.14e-05	0.000179	CcSEcCtD
Penicillamine—SLCO1B1—Metabolism—CHRM3—epilepsy syndrome	4.01e-05	0.000873	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—KCNJ11—epilepsy syndrome	4.01e-05	0.000873	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.73e-05	0.000813	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.66e-05	0.000797	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCG2—epilepsy syndrome	3.27e-05	0.000712	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2C19—epilepsy syndrome	3.19e-05	0.000694	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP11A1—epilepsy syndrome	3.17e-05	0.000689	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.14e-05	0.000684	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.87e-05	0.000624	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CYP2D6—epilepsy syndrome	2.86e-05	0.000622	CbGpPWpGaD
Penicillamine—SLCO1B1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.72e-05	0.000593	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ADRA2A—epilepsy syndrome	2.72e-05	0.000592	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—BCHE—epilepsy syndrome	2.71e-05	0.00059	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—SLC2A1—epilepsy syndrome	2.58e-05	0.000563	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PLCB1—epilepsy syndrome	2.56e-05	0.000556	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—TH—epilepsy syndrome	2.55e-05	0.000554	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.51e-05	0.000546	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	2.13e-05	0.000463	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—CAT—epilepsy syndrome	2.1e-05	0.000457	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	2.04e-05	0.000444	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	1.9e-05	0.000413	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AGT—epilepsy syndrome	1.66e-05	0.000362	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—APOE—epilepsy syndrome	1.63e-05	0.000355	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—POMC—epilepsy syndrome	1.4e-05	0.000305	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—ALB—epilepsy syndrome	1.28e-05	0.000278	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	1.12e-05	0.000243	CbGpPWpGaD
Penicillamine—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	5.61e-06	0.000122	CbGpPWpGaD
